Minocycline for acute stroke treatment: a systematic review and meta-analysis of randomized clinical trials
ConclusionsAlthough data is limited, minocycline demonstrated efficacy and seems a promising neuroprotective agent in acute stroke patients, especially in AIS subgroup. Further RCTs are needed to evaluate the efficacy and safety of minocycline among ICH patients.
Source: Journal of Neurology - Category: Neurology Source Type: research
More News: Brain | Clinical Trials | Databases & Libraries | Heart Attack | Hemorrhagic Stroke | Ischemic Stroke | Minocycline | Neurology | Solodyn | Stroke